Holmes V V - OmicsDI

Show results for

Unknown (975)
Metabolomics (51)
Genomics (43)
Transcriptomics (32)
Proteomics (24)
Models (1)

Organisms

Homo sapiens (57)
Mus musculus (11)
Heterocephalus glaber (5)
Candida albicans (3)
Bathyergus suillus (2)
Staphylococcus aureus (2)
Burkholderia gladioli (1)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (1)
Saccharomyces cerevisiae SK1 (1)
Medicago truncatula (1)
Solanum tuberosum (1)
Escherichia coli (1)
Bienertia sinuspersici (1)
Campylobacter jejuni (1)
Chenopodium quinoa (1)
Drosophila melanogaster (1)
Lithobates sylvaticus (1)
Mesocricetus auratus (1)
Neisseria gonorrhoeae FA 1090 (1)
Nitrosopumilus maritimus SCM1 (1)
Oryza sativa (1)
Plasmodium falciparum 365.1 (1)

Repository

MetaboLights (49)
biostudies-arrayexpress (42)
EGA (31)
pride (24)
GNPS (2)
ENA (2)
BioModels (1)

Tissue

Cell culture (7)
Epithelial cell (3)
Brain (2)
Permanent cell line cell (2)
Blood (1)
Blood cell (1)
Embryonic stem cell (1)
Intestinal juice (1)
Leaf (1)
Liver (1)
Mouth (1)
Oropharynx (1)
Ovary (1)
Plant cell (1)
Prokaryotic cell (1)
Seed (1)
Seminal plasma (1)

Disease

Breast cancer (3)
Alpha-1 antitrypsin deficiency (1)
Disease free (1)
Gonorrhea (1)
Plasmodium falciparum malaria (1)

Technology Type

Mass spectrometry (26)
Mass Spectrometry (24)
NMR spectroscopy (21)
Shotgun proteomics (11)
Bottom-up proteomics (9)
Mass spectrometry assay (4)
Data-dependent acquisition (3)
NMR spectroscopy assay (2)
SWATH MS (2)
AB SOLiD 4 System, Illumina HiSeq 2500, Illumina HiSeq 2000, AB SOLiD System 3.0 (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Gel-based experiment (1)
HDMSE (1)
SRM/MRM (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (14)
Liquid Chromatography MS - positive - reverse phase (12)
Illumina NovaSeq 6000 (9)
Nuclear Magnetic Resonance (NMR) - (9)
Bruker (8)
Nuclear Magnetic Resonance (NMR) (6)
Liquid Chromatography MS - positive - hilic (4)
Xevo G2 QTOF (Waters) (4)
Pacbio Revio (2)
PromethION (2)
Direct infusion MS - negative (2)
Direct infusion MS - positive (2)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (2)
Liquid Chromatography MS - negative - hilic (2)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
6470 Triple Quadrupole LC/MS (Agilent instrument model) (1)
6520A Quadrupole Time-of-Flight LC/MS (1)
7820A/5977B GC/MS (Agilent instrument model) (1)
Orbitrap Fusion (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - alternating – hilic (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
MaXis (Bruker) (1)
Nuclear Magnetic Resonance (NMR) - - - Bruker (1)
Nuclear Magnetic Resonance (NMR) - - - Varian (1)

Publication Date

2021 (12)
2026 (11)
2025 (11)
2023 (10)
2024 (8)
2017 (8)
2022 (7)
2020 (6)
2011 (6)
2019 (6)
2018 (6)
2015 (5)
2013 (5)
2012 (4)
2010 (4)
2014 (3)
2008 (2)
2016 (2)
2006 (1)

CHEBI ID

CHEBI:16919 (21)
CHEBI:15891 (20)
CHEBI:16737 (20)
CHEBI:15354 (19)
CHEBI:15428 (18)
CHEBI:16449 (18)
CHEBI:17750 (18)
CHEBI:27266 (17)
CHEBI:30769 (17)
CHEBI:15366 (16)
CHEBI:78320 (16)
CHEBI:15724 (15)
CHEBI:17368 (15)
CHEBI:24898 (15)
CHEBI:25094 (15)
CHEBI:28044 (15)
CHEBI:16704 (14)
CHEBI:17295 (14)
CHEBI:17568 (14)
CHEBI:18237 (14)
CHEBI:25017 (14)
CHEBI:28300 (14)
CHEBI:30751 (14)
CHEBI:15741 (13)
CHEBI:20067 (13)
CHEBI:27897 (13)
CHEBI:32816 (13)
CHEBI:15971 (12)
CHEBI:16335 (12)
CHEBI:16414 (12)

Metabolite Name

Creatine (16)
Creatinine (14)
Choline (13)
Glycine (12)
Taurine (11)
Betaine (10)
Hypoxanthine (10)
Alanine (9)
L-Alanine (9)
L-Isoleucine (9)
L-Phenylalanine (9)
L-Valine (9)
Valine (9)
Xanthine (9)
Acetate (8)
Ethanol (8)
Glucose (8)
Isoleucine (8)
Proline (8)
Uridine (8)
Arginine (7)
Carnitine (7)
Glutamine (7)
Inosine (7)
L-Glutamine (7)
L-Histidine (7)
L-Leucine (7)
L-Tyrosine (7)
Methanol (7)
Phenylalanine (7)

IsPrivate

False (1)

First Public Date

2025 (1)
2022 (1)

Modelling Approach

Ordinary differential equation model (1)

Study type

Transcription profiling by array (22)
ChIP-seq (5)
DNA-seq (4)
Comparative genomic hybridization by array (2)
Exome sequencing (2)
RNA-seq of total RNA (2)
RNA-seq of coding RNA (2)
Unknown experiment type (1)
ATAC-seq (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (122)
2021 (115)
2025 (85)
2023 (82)
2024 (78)
2020 (78)
2019 (60)
2016 (55)
2015 (47)
2018 (44)
2014 (40)
2012 (37)
2017 (32)
2013 (31)
2011 (27)
2026 (23)
2010 (20)
2009 (13)
2008 (10)
2006 (5)
2007 (3)
2000 (3)
2004 (2)
2002 (2)
2003 (1)
2001 (1)
1999 (1)

Lab affiliation

Department of Chemistry and Biomolecular Sciences, University of Ottawa, Canada (4)
Université Paris-Saclay, INRAE, AgroParisTech, Micalis Institute, Jouy en Josas, France (2)
Washington University in St. Louis (2)
Cornell University, Ithaca NY (USA) (1)
Department of Anatomy and Developmental Biology, Australian Regenerative Medicine Institute, Monash University, Australia (1)
Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada, K1H 8M5 (1)
Department of Biochemistry, UC Riverside (1)
Department of Biology, University of Ottawa, Ottawa, Canada, K1N 6N5 (1)
Department of Chemical Engineering and Analytical Chemistry, Institute for Research on Nutrition and Food Safety (INSA·UB), University of Barcelona, 08028 Barcelona, Spain (1)
Department of Molecular Physiology, Leiden University (1)
Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, USA (1)
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany (1)
John van Geest Cancer Research Centre, Nottingham Trent University (1)
Oncology (1)
Ottawa Institute of Systems Biology and Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, ON, Canada (1)
School of Medicine, Deakin University, Geelong, 3216, Australia (1)
University of Liverpool (1)
University of Liverpool, Centre for Proteome Research, Biosciences Building, Crown Street, Liverpool, UK (1)
University of Washington (1)

Tags

xref:PubMed:35638822 (1)
xref:EuropePMC:PMC9769393 (1)

Previous page
1 / 113
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 113
Next page

Sort by:

Relevance

Page size

Novel mRNA isoforms of the sodium channels Na(v)1.2, Na(v)1.3 and Na(v)1.7 encode predicted two-domain, truncated proteins.

Not available

S-EPMC2726981 | biostudies-literature

Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections.

Not available

S-EPMC11271292 | biostudies-literature

Holmes2006 - Hill's model of muscle contraction

Holmes2006 - Hill's model of muscle contraction This model is described in the article: Teaching from classic papers: Hill's model of muscle contraction. Holmes JW. Adv Physiol Educ 2006 Jun; 30(2): 67-72 Abstract: A. V. Hill's 1938 paper "The heat of shortening and t...

2024-09-02 | BIOMD0000000677 | BioModels

Exploring the Pharmacokinetics of Phenoxymethylpenicillin (Penicillin-V) in Adults: A Healthy Volunteer Study.

Not available

S-EPMC8684501 | biostudies-literature

Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability.

Understanding the human milk metabolome can help inform infant nutrition and health. Untargeted metabolomics was used to study breast milk from 31 healthy participants to assess the shared metabolites in milk from participants with various backgrounds and understand how different demographic, health...

2024-10-04 | MTBLS2419 | MetaboLights

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has not been evaluated. We conducted a multicenter phase I trial combining ...

2025-02-27 | MTBLS711 | MetaboLights

Association of factor V gene polymorphism with arteriovenous graft failure.

Not available

S-EPMC3328616 | biostudies-literature

Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.

Not available

S-EPMC7493828 | biostudies-literature

A qualitative evaluation of team and family perceptions of family-based treatment delivered by videoconferencing (FBT-V) for adolescent Anorexia Nervosa during the COVID-19 pandemic.

Not available

S-EPMC9321306 | biostudies-literature

Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels.

Not available